โดนัลด์ ทรัมป์ · Nation Thailand
Trump announces plan for 100% tariff on generic drug imports to boost US production
Compiled by KHAO Editorial — aggregated from 1 outlet. See llms.txt for citation guidance.
◌ Single Source
US President Donald Trump’s announcement of plans to raise tariffs on imported generic drugs has sent fresh shockwaves through the global pharmaceutical industry. Under the plan, a 100% tariff would be imposed from August 2028, rising to 200% in August 2029, unless manufacturers decide to invest in building factories and installing machinery in the United States within the specified timeframe.
Key facts
- However, Thailand’s pharmaceutical export figures show that the United States is not a major market for Thai drug manufacturers
- The US ranked ninth, receiving exports worth 1.044 billion baht, equivalent to about 4.9% of Thailand’s total pharmaceutical exports.
- The US remained in ninth place, with shipments worth 361 million baht, or about 4% of the total.
- Thailand exported pharmaceutical products worth 21.505 billion baht in 2025, covering medicines and related goods.
- The same pattern continued during the first five months of 2026, when Thailand exported pharmaceutical products worth 8.908 billion baht.
Summary
However, Thailand’s pharmaceutical export figures show that the United States is not a major market for Thai drug manufacturers. Exports to the US account for less than 5% of Thailand’s total pharmaceutical exports, suggesting that the direct impact of the proposed measure on the country may remain limited.
What Thailand must watch more closely, however, is the emerging competition to attract global pharmaceutical production. This could reshape investment flows and alter the industry’s competitive landscape over the longer term.